Truvada Contracts

If your law firm is embarking on a Truvada marketing campaign, Atraxia Media can help.

Our team serves law firms nationwide, helping our clients resolve their challenges in acquiring new client business. Through our people-based and data-driven marketing strategies, we can help you qualify and retain more claims from individuals who suffered side effects from Truvada. Many patients who take Truvada, and similar HIV drugs that are part of the class of medications known as tenofovir disoproxil fumarate (TDF), are suing the drug producer Gilead Sciences, Inc. TDF drugs are also sold under the names Atripla, Complera, Stribild, Symfi-Lo, and Viread among other lesser-known brands.

Current signed contract costs: ***subject to change

Truvada Facts & History Information

Truvada is a pill-based drug that prevents HIV cells from multiplying but does not cure HIV-1 infections or AIDS. The drug's role is to help reduce the risk of getting HIV-1 infections.

Gilead's inaugural HIV drug, Viread, received U.S. Food and Drug Administration (FDA) approval in 2001. Gilead bought the rights to TDF - that had been around since the 1980s but was not feasible for AIDS treatment - and modified it so it could be taken orally in pill form. That is when the drug started getting used to stop HIV from taking hold and prevent it from spreading.

Several studies have linked Truvada and the other TDF-based HIV pills with serious side effects, including bone density loss, lactic acidosis, and kidney problems. These side effects have led to hundreds of Truvada lawsuits against Gilead Sciences, Inc.


Truvada claims against Gilead Sciences, Inc. are still new and, accordingly, settlements are a long way away. In the future, the courts are likely to consolidate current lawsuits, and the potential lawsuits of thousands of people who have suffered from the serious complications of Truvada, into multidistrict litigation (MDL). People who took Gilead's other HIV drugs containing TDF are also expected to come forward and file lawsuits for compensation.

Plaintiff Allegations

Allegations against Gilead Sciences, Inc include:

  • Failing to disclose Truvada's significant risk for toxicity and bone and kidney damage.
  • Failing to warn doctors and patients of the kidney and bone risks in all patients. Accordingly, people could not make informed decisions and, potentially, avoid their injuries.
  • Misrepresenting the risks and benefits of Truvada to doctors and patients so it could sell these drugs.
  • Withholding a safer version of these drugs and forcing victims to continue to experience damaging side effects.



  • Starting with 2018, hundreds of lawsuits against Gilead have been filed by individual victims.
  • The largest global AIDS organization, AIDS Health Foundation (AHF), helped file one class-action lawsuit that represents TDF victims.
  • The majority of Truvada cases are in California, but there are a handful of cases in Delaware, Louisiana, and other states.


  • In a victory over Gilead, in February 2019, a California Superior Court ruled that plaintiffs' claims may proceed.


  • In January 2020, a lawsuit was filed with the U.S. District Court, the Northern District of California by 86 plaintiffs who suffered kidney, bone Injuries from side effects of Gilead HIV drugs.

Your legal team is, undoubtedly, experienced and well-equipped to deal with cases in mass tort litigation, but it's often difficult to address every single potential client. This is especially true when news breaks and you receive a flood of calls seeking legal advice.

At Atraxia Media, because of our robust infrastructure, technology, and experience, we can ensure that your mass tort Truvada campaign will be as successful as possible. We can efficiently and effectively handle the advertising, screening, and qualifying of your firm's potential clients that mass tort litigation requires. Call us today if your firm is interested in the increase in your client base and revenue for mass tort campaigns.